DOI QR코드

DOI QR Code

Finding of a Characteristic Reactive Region Common to Some Series of Chemical Carcinogens

  • Published : 1985.04.20

Abstract

Quantum chemical calculations were carried out to explain how the electronic states of some series compounds vary with metabolic activation. Compounds studied included aromatic amines and amides, polycyclic hydrocarbons, and a few alkylating agents that do not require metabolic activation. The 1, 2 and 4 positions forming the trans-butadiene frame of a molecule, henceforth referred to as "the trans 1, 2, 4 region", have seen to be important positions for the prediction of carcinogenic activity of these compounds. It is also evident that their electrophilic properties increase with metabolic activation. That is the sum of ${\pi}$-electron densities of the trans 1, 2, 4 region in the lowest unoccupied molecular orbital (LUMO) has been found to increase in the order of precarcinogens < proximate-ones < the carbocation ultimate-ones. This is consistent with the fact that chemical carcinogens become more strongly electrophilic with activating. This region not only provides a unified view of structurally diverse carcinogens, but also predicts uniformity in their reactive sites. Accordingly, we suggest that an understanding of the trans 1, 2, 4 region would be helpful in elucidating the mechanism of carcinogenesis.

Keywords

References

  1. Brit. M. J. v.1 R. Robinson
  2. J. Amer. Chem. Soc. v.63 W. F. Bruce
  3. J. Chem. Phys. v.22 M. M. Moodie;C. Reid
  4. J. Amer. Chen. Soc. v.62 R. N. Jones
  5. Phys. Chem. v.42 O. Schmidt
  6. Rev. Sci. v.84 A. Pullman;B. Pullman
  7. Adv. Cancer Res. v.3 A. Pullman;B. Pullman
  8. Int. J. Cancer v.16 H. W. Taylor
  9. Selecta Chimica v.20 K. Fukui
  10. Cancer Res. v.30 James A. Miller
  11. Adv. Cancer Res. v.18 C. Heidelberger
  12. Science v.185 D. M. Jerina;J. W. Daly
  13. Adv. Cancer Res. v.20 P.Sime
  14. Drug Metabolism D. M. Jerina;J. W. Daly
  15. J. Toxicol. Environ. Health v.2 R. E. Lehr;D. M. Jerina
  16. J. Kor. Chem. Soc. v.24 B. K. Park.
  17. Quantum Biochemistry v.104 B. Pullman;A. Pullman
  18. J. Chem. Physics v.39 Ronald Hoffmann
  19. Cancer Research v.35 J-K. Lin;James A. Miller;Elizabeth C. Miller
  20. Cancer Research v.38 Elizabeth C. Miller
  21. Cancer Research v.30 Jack R. DeBaun;Elizabeth C. Miller;James A. Miller
  22. Chem. Biol. Interaction v.38 D. L. Tillis;K. M. Straub;F. F. Kadlubar
  23. Biochem. Basis Chem. Teratog. Jeanne M. Manson
  24. Cancer Research v.30 Jame A. Miller
  25. Microsome and Drug oxidation D. M. Jerina;R. E. Lehr
  26. Proc. Natl. Acad. Sci. U.S. v.73 D. R. Thakker;H. Yagi;A. Lu;W. Levin;A. H. Conney;D. M. Jerina
  27. Science v.193 I. B. Weinstein(et al.)